Canada extends the shelf life of the AstraZeneca jab by one month


People get their Covid-19 shot during a “Doses After Dark” night-time vaccination clinic in Mississauga, Ontario, on May 15, 2021.

Canadian health authorities announced Saturday that they were rolling back the expiration date of nearly 50,000 doses of AstraZeneca coronavirus vaccine in a month.

Health Canada stated in a statement its approval to extend the shelf life of two batches of from May 31 to July 1 received the support of “. “

“This change will ensure that provinces and territories can use their existing inventory and provide Canadians with access to much-needed doses of the vaccine,” the agency said.

A Health Canada spokesman said as of May 22, there were about 49,000 doses of AstraZeneca in the country that expired on May 31. CBC reported that most were in the province of Ontario.

The Canadian health authorities had previously approved a six-month period for the Covid-19 vaccine from AstraZeneca.

But they said they received information from the company on May 27 that included “product stability data and mathematical modeling” that showed the two batches could be used safely and effectively for another month.

Several provinces have announced this month their decision to suspend the use of the AstraZeneca vaccine for people receiving their first shot, due to rare cases of blood clots.

But Canadians who had received a first dose of AstraZeneca were able to get their second scheduled dose.

Just over 55 per cent of Canada’s 38 million people have received a dose of Covid-19 vaccine and 5 per cent have received two doses.

In addition to AstraZeneca, Pfizer, Moderna and Johnson & Johnson vaccines are approved for use in Canada.

Ontario resumes use of AstraZeneca, but only as a second dose

© 2021 AFP

Citation: Canada extends the life of the AstraZeneca jab one month (2021, May 30) recovered on May 30, 2021 at .html

This document is subject to copyright. Apart from any fair treatment for the purposes of private study or research, no part may be reproduced without written permission. Content is provided for informational purposes only.

Source link